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Abstract 
Hypothyroidism and the Development of Hypertension 
 
Name: Kaleb Fischer Short 
Degree: Master of Science in Biology 
Institution: Minnesota State University, Mankato 
Mankato, Minnesota, 2015.  
 
Low thyroid hormone (TH) in adulthood is associated with increased risk of 
cardiovascular disease, including risk of hypertension. The Spontaneously Hypertensive 
Rat (SHR), exhibits alterations in thyroid function when compared to normotensive 
controls. Interestingly, inhibiting thyroid gland function before 4 weeks of age prevented 
hypertension in the SHR, indicating that TH is involved in the etiology of SHR 
hypertension. However, these studies utilized tail-cuff photoplethysmography (PPG), 
which is known to have stress-induced artifacts, and did not compare effects in the 
normotensive parent strain Wistar Kyoto (WKY) rat.  Therefore, it is uncertain whether 
TH is responsible for an elevation in baseline blood pressure or whether hypertension in 
the SHR is caused by abnormal TH action in the cardiovascular system.  
Considering this, the purpose of the present study was to investigate the effect of 
hypothyroidism on the SHR and its parent strain, WKY on blood pressure. To study the 
effect of thyroid hormone on blood pressure, we inhibited thyroid hormone production in 
WKY and SHR male rats with 1% KClO4 and 0.05% MMI in drinking water from 4-14 
weeks-of-age. Rats were allowed to recover from treatment weeks 14-17. Blood pressure 
was monitored weekly by tail-cuff PPG from 4-15 weeks and by implantable remote 
transmitters from 11-17 weeks. Pressure natriuresis was evaluated using flame 
photometry.    
 
 
PPG data was consistent with previous literature that indicated hypothyroidism 
prevented hypertension in the SHR, but remote transmitter data indicated a comparable 
reduction in systolic (SAP) and mean arterial pressure (MAP) between strains. The 
observed difference in PPG can be explained by an exaggerated response of SAP to stress 
in SHRs which is normalized by hypothyroid treatment. Strain differences were observed 
in the effect of treatment on diastolic arterial pressure (DAP), pulse pressure (PP), heart 
rate, and pressure natriuresis. Endothelial dysfunction and increased arterial stiffness in 
the SHR provide potential explanations for differences in DAP, PP, and pressure 
natriuresis.  
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Introduction 
 Low thyroid hormone in adulthood is associated with increased risk of 
cardiovascular disease (Rhee, Curhan, Alexander, Bhan, & Brunelli, 2013), including risk 
of hypertension (Saito, Ito, & Saruta, 1983; Streeten, Anderson, Howland, Chiang, & 
Smulyan, 1988). Interestingly, the Spontaneously Hypertensive Rat (SHR), a murine 
model of hypertension, exhibits abnormal thyroid function when compared to 
normotensive controls (Aoki, 1963a, 1963b; Fregly, 1975; Werner, Manger, Radichevich, 
Wolff, & von Estorff, 1975; Yamabe, 1970). Additionally, thyroid gland inhibition 
starting at 4 weeks of age has been found to prevent the onset of hypertension entirely in 
the SHR, indicating that thyroid hormone is involved in the development of hypertension 
(Aoki, 1963b; Rioux & Berkowitz, 1977). 
 Although these reports indicated involvement of thyroid hormone in the 
establishment of hypertension in the SHR, the effect of hypothyroidism on blood pressure 
has not been compared between the SHR and a normotensive strain. Therefore, it is 
uncertain whether thyroid hormone is responsible for a baseline elevation in blood 
pressure set point or whether hypertension in the SHR is caused by abnormal thyroid 
action in the cardiovascular system. 
Given the abnormal thyroid function in the SHR and prevention of hypertension 
in the SHR by thyroidectomy in previous studies, it is hypothesized that: hypertension in 
Spontaneously Hypertensive Rats is caused, in part, by abnormal thyroid hormone 
action in the cardiovascular system.  
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In testing this hypothesis, we propose that the inhibition of thyroid gland 
activity will result in a greater overall decrease in mean arterial pressure in SHRs 
when compared to controls, than the decrease found in WKY rats given the same 
treatment.  
Additionally, it is known that hypothyroidism induces reduced cardiac beta 
adrenergic receptor numbers, subsequently decreasing sensitivity to sympathetic 
stimulation (Bilezikian & Loeb, 1983; Rioux & Berkowitz, 1977). As tail-cuff 
photoplethysmography evokes a stress response in rats, it is unclear whether the decrease 
in systolic pressure in hypothyroid rats observed in prior studies is due to a basal 
reduction in systolic pressure or due to a reduction in the stress-induced sympathetic 
response. Prior research indicates that SHRs have higher sympathetic responsivity to 
restraint than normotensive rats (Chiueh & Kopin, 1978). Therefore, it is hypothesized 
that: hypothyroid rats exhibit a reduced response of systolic arterial pressure to 
sympathetic stimulation. SHR hypothyroid rats will exhibit a greater reduction in 
systolic arterial pressure in response to sympathetic stimulation than WKY 
hypothyroid rats. 
In testing this hypothesis, we propose that the inhibition of thyroid gland 
activity will result in a smaller increase in systolic arterial pressure in response to 
acute stress when compared to euthyroid counterparts. SHR hypothyroid rats will 
exhibit a greater reduction in the systolic arterial pressure response to stress than 
WKY hypothyroid rats when compared to their euthyroid counterparts. 
Lastly, hypothyroidism impairs nitric oxide synthesis (Virdis et al., 2009). Nitric 
oxide has a known effect on the pressure natriuresis response in rats (Guarasci & Kline, 
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1996). Since prior studies have reported that chronic hypothyroidism has no effect on the 
pressure natriuresis response in rats (Vargas, Atucha, Sabio, Quesada, & Garcia-Estan), it 
is hypothesized that: developmentally hypothyroid rats will exhibit a comparable 
pressure natriuresis response to euthyroid rats. 
In testing this hypothesis, we propose that the inhibition of thyroid gland 
activity at weaning will result in an acute pressure natriuresis response comparable 
to that observed in euthyroid counterparts.  
Literature Review 
Thyroid Hormone Secretion and Regulation 
 Thyroid hormones, tetraiodothyronine (T4 or thyroxine) and triiodothyronine (T3), 
are hormones synthesized by the thyroid gland, a gland which resembles a bow tie in 
shape and size and is situated on the anterior side of the trachea. Iodine enters the 
follicular cells of the thyroid gland by active transport and is covalently bound to tyrosine 
residues within thyroglobulin, a glycoprotein synthesized within the follicular cells. This 
covalent bonding is referred to as iodination and forms either monoiodotyrosine (MIT) or 
diiodotyrosine (DIT). Two DIT molecules combine to form T4 and the combination of 
one MIT and one DIT form T3. Ninety-five percent of thyroid hormone secreted by the 
thyroid gland is T4 (Gard, 1998). 
 T4 binds to thyroid hormone receptors with less affinity than T3, and is often 
thought of as a precursor to T3. The deiodinase enzymes function to remove iodine atoms 
from iodothyronines as a mechanism of activation or deactivation within target tissues. 
Type 2 deiodinase (D2), removes an iodine atom from the outer ring of T4 to create T3 
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(activation). Type 3 deiodinase (D3) can remove an iodine atom from the inner ring of T4 
to create reverse T3 (rT3) (inactivation) or remove an iodine atom from the inner ring of 
T3 to create T2 (inactivation).  Type 1 deiodinase (D1) is found most commonly in the 
liver and kidney and can remove an iodine atom from either ring of thyroid hormones to 
make T2, rT3, or T3 (Bates, St Germain, & Galton, 1999). 
 Circulating thyroid hormone in the blood is regulated via the hypothalamic-
pituitary-thyroid (HPT) axis. Thyrotropin releasing hormone (TRH) is produced by 
neurons of the paraventricular nucleus of the hypothalamus. TRH stimulates the release 
of thyroid stimulating hormone (TSH) production and release by the anterior pituitary. 
TSH stimulates the thyroid gland to increase synthesizing activity of thyroid hormones. 
Thyroid hormones act on the pituitary gland and hypothalamus to inhibit the release of 
TSH and TRH, respectively, via a classical negative feedback loop (Gard, 1998). 
 Thyroid hormone receptors mediate the majority of biological processes regulated 
by thyroid hormones. There are two extant thyroid receptor genes, TRα and TRβ. The T3 
receptor product of TRα is TRα1 and is expressed primarily in the heart, brain, and 
skeletal muscle. The T3 receptor products of TRβ are TRβ1, which is systemically 
expressed, TRβ2, which is primarily expressed in the retina, brain, and inner ear, and 
TRβ3, which is primarily expressed in the kidney, liver, and lung (Cheng, Leonard, & 
Davis, 2010). 
Arterial Pressure Regulation 
 Mean arterial pressure (MAP) is the average pressure in the arteries over one 
cardiac cycle, which includes systole (ventricular contraction), and diastole, (ventricular 
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relaxation/filling). Diastolic arterial pressure (DAP) is the minimum pressure in the 
arteries in a cardiac cycle. Systolic Arterial Pressure (SAP) is the maximum pressure in 
the arteries in a cardiac cycle. Pulse Pressure (PP) is the difference between SAP and 
DAP. 
MAP is a function of total peripheral resistance (TPR), the amount of resistance 
that opposes blood flow in the systemic circulation, and cardiac output (CO), the amount 
of blood pumped by the heart each minute (L/min). Cardiac output is the product of 
stroke volume (SV), the amount of blood pumped from the ventricles of the heart in each 
cardiac cycle (L), and heart rate (beats per minute (bpm)). Acutely, when a decrease in 
MAP occurs, it stimulates the arterial baroreceptors, and the central nervous systems 
enacts an increase in sympathetic stimulation. This increase in sympathetic stimulation 
functions to increase heart rate, increase total peripheral resistance, and increase stroke 
volume. Long-term, MAP is increased by the kidneys through increasing fluid and ion 
reabsorption and decreasing fluid and ion excretion, resulting in an increase in blood 
volume (Mohrman & Heller, 1997). The larger blood volume increases stroke volume, 
and subsequently MAP. 
Clinical Effects of Hypothyroidism on the Cardiovascular System 
 In the hypertensive population, there is a 30-50% increased prevalence of 
hypothyroidism compared to the general population (Fletcher & Weetman, 1998; 
Streeten et al., 1988). A review of published data indicates that hypertension occurs in 
about 22% of hypothyroid patients compared to 3-18% of the general population (Danzi 
& Klein, 2003). Clinical cardiovascular observations in hypothyroidism include 
bradycardia, narrowed pulse pressure, and diastolic hypertension (I. Klein & Ojamaa, 
15 
 
2001). Additionally, subclinical hypothyroidism has been reported as a risk factor for 
atherosclerosis and myocardial infarction (Hak et al., 2000). A recent study found that 
subclinical hypothyroidism and hypothyroidism were associated with a higher rate of all-
cause mortality in patients with congestive heart failure (Rhee et al., 2013). In most cases, 
the effects of hypothyroidism on blood pressure are reversible with thyroid hormone 
replacement (Fletcher & Weetman, 1998; Saito & Saruta, 1994). 
Effects of Thyroid Hormone on the Heart 
Thyroid hormone excess has been found to increase cardiac contractility in 
humans (Amidi, Leon, DeGroot, Kroetz, & Leonard, 1968), rats (Korecky, Zak, 
Schwartz, & Aschenbrenner, 1987), and cats (Buccino, Spann, Pool, Sonnenblick, & 
Braunwald, 1967). The expression and subsequent production of phospholamban in 
cardiomyocytes is negatively transcriptionally regulated, in part, by T3 (Kiss, Jakab, 
Kranias, & Edes, 1994). Phospholamban regulates the active transport of Ca2+ into the 
sarcoplasmic reticulum by the Ca2+-ATPase pump (SERCA2). Conditional SERCA2 
knockout mice have severely impaired diastolic and systolic function (Louch et al., 
2010). Mice lacking phospholamban are observed to have increased cardiac contractility 
and when treated with thyroid hormones, there was no additional increase in contractility. 
This suggests that the relationship between cardiac contractility and thyroid hormones is 
primarily mediated through phospholamban activity (Kiss et al., 1998). Overall, this 
suggests T3 has an important influence on systolic contraction and diastolic relaxation 
and provides a mechanistic explanation of clinical observations of reduced stroke volume 
and narrowed pulse pressure in hypothyroid patients.  
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Hypothyroidism reduces beta adrenergic receptors by 30-40% and increases 
alpha-1 adrenergic receptors in the rat heart (Bilezikian & Loeb, 1983). This finding 
would be consistent with clinical observations of bradycardia. Interestingly, it has been 
found that changes in heart rate, contractility and blood pressure with changes in thyroid 
hormone levels occur independently of the beta adrenergic receptor activity, indicating 
the complex nature of these effects. (Bachman et al.). 
Thyroid hormone positively regulates the alpha myosin heavy chain and 
negatively regulates the beta myosin heavy chain in the heart (I. Klein & Danzi, 2007). 
Thyroid receptor beta and alpha 1 are involved in the negative regulation of the beta 
myosin heavy chain as well as the induction of the myosin heavy chain (Mansen, Yu, 
Forrest, Larsson, & Vennstrom, 2001). Shifts from alpha to beta myosin in transgenic 
mice have been found to reduce contractile function, increase systolic and diastolic 
ventricular volumes (Krenz & Robbins, 2004). Together these findings outline changes in 
myosin chain ratios associated with hypothyroidism as a potential mechanism of diastolic 
dysfunction observed in hypothyroidism. 
Hemodynamic Effects of Thyroid Hormone 
T3 decreases vascular resistance acutely by dilating the arterioles (Park et al., 
1997). This is a direct relaxational effect of T3 on vascular smooth muscle cells (Ojamaa, 
Klemperer, & Klein, 1996). Clinically, T3 has been administered to promote and facilitate 
increases in cardiac output and vasodilation in the pathological failing heart and normal 
heart in instances of advanced congestive heart failure (Hamilton et al., 1998) and in 
coronary bypass patients (Klemperer et al., 1995).  This relaxational effect can, in part, be 
attributed to thyroid hormone involvement in the synthesis of nitric oxide, a vasodilator. 
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In hyperthyroidism, nitric oxide synthesis is enhanced and in hypothyroidism, nitric 
oxide synthesis is impaired through thyroid hormone regulation of nitric oxide synthase 
(Virdis et al., 2009).  
Chronic and acute inhibition of nitric oxide synthase is reported to blunt the 
response of sodium excretion to increases in blood pressure, or pressure natriuresis 
(Guarasci & Kline, 1996). Since nitric oxide synthase inhibition is associated with 
decreased pressure natriuresis and nitric oxide synthase is positively regulated by thyroid 
hormone, augmented pressure natriuresis in hyperthyroidism and blunted pressure 
natriuresis in hypothyroidism would be anticipated. However, hyperthyroidism blunts the 
pressure natriuresis response in rats, but chronic hypothyroidism is not associated with an 
alteration of the pressure natriuresis response (Vargas et al., 1994). This suggests that 
alternative mechanisms regulating pressure natriuresis compensate (or in the case of 
chronic hyperthyroidism, overcompensate) for chronic changes nitric oxide synthase 
activity associated with altered thyroid states. 
 Additionally, hypothyroidism has been observed to decrease sensitivity of rat 
aortic smooth muscle to alpha and beta adrenergic agonists (Rahmani, Cheema, Sen, 
Peoples, & Riley, 1987; Rioux & Berkowitz, 1977). As the dominant effect of adrenergic 
receptors in vascular smooth muscle is to constrict, the decrease in adrenergic sensitivity 
resulting from hypothyroidism should have a vasodilatory effect and decrease resistance. 
However, increased arterial stiffness and a related increase in systemic vascular 
resistance and a subsequent increase in afterload are observed in hypothyroidism 
(Obuobie et al., 2002). Increased afterload and systemic vascular resistance should result 
in an increase in blood pressure. 
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In hyperthyroidism, the decrease in systemic vascular resistance leads to a fall in 
effective arterial filling volume, causing an increase in renin release and activation of the 
renin-angiotensin system (Resnick & Laragh, 1982). An activation of the renin-
angiotensin system stimulates renal sodium absorption and a subsequent increase in 
plasma volume (I. L. Klein, G.S., 2000). Additionally, thyroid hormone stimulates 
erythropoiesis (Dainiak, Hoffman, Maffei, & Forget, 1978). In hyperthyroidism, the 
combination of an increase in plasma volume and erythropoiesis results in an overall 
increase in blood volume and preload. The opposite is true in a hypothyroid state and the 
net effect of decreased preload and blood volume is a direct decrease in cardiac output (I. 
Klein & Danzi, 2007). The combined direct effects of changes in preload, contractility, 
heart rate and blood volume result in a 50-300 percent increase in cardiac output in 
hyperthyroid individuals, compared to euthyroid counterparts and a 30-50 percent 
decrease in cardiac output in hypothyroid individuals compared to euthyroid counterparts 
(I. Klein & Danzi, 2007). 
Thyroid Hormone in Nervous Control of the Cardiovascular System 
 In addition to local tissue effects of thyroid hormone in the cardiovascular system, 
recent research implicates thyroid hormone involvement in central nervous control of 
cardiac function (Fliers, Klieverik, & Kalsbeek, 2010).  Injection of thyroid hormone into 
the hypothalamus of rats inhibits the AMPK pathway and inhibits sympathetic nervous 
system activity (Lopez et al., 2010), though studies of chronic inhibition of thyroid 
activity indicate decreased response to sympathetic stimulation (Bilezikian & Loeb), 
indicating that chronic vs. acute changes in thyroid state and local thyroid levels 
determine the ultimate effect on sympathetic activity and responsiveness to sympathetic 
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stimulation. Recently, a group of thyroid hormone sensitive neurons in the anterior 
hypothalamus involved in cardiovascular regulation have been observed in decreased 
numbers in mice with defective TRα1receptors. These mice were also observed to have a 
permanent increase in blood pressure even after the administration of T3; indicating that 
developmental thyroid signaling is critical in the establishment of cardiovascular 
mechanisms involved in the regulation of blood pressure (Mittag et al., 2013).  
Thyroid Function in the Rat Model of Hypertension 
The Spontaneously Hypertensive Rat (SHR), a model of essential hypertension, 
has altered thyroid function. A study of thyroid function in SHRs found plasma and 
pituitary TSH were significantly elevated and plasma T4 was significantly lower in the 
SHR when compared to normotensive WKY rats. Plasma T3, however, was found to be 
normal. The monoiodotyrosine/diiodotyrosine ratio (MIT/DIT ratio) was found to be 
elevated in the SHR, suggesting an abnormality in thyroidal synthesis of thyroid 
hormones. Consistent with this idea, abnormalities in hydrolytic enzymes and 
thyroglobulin were reported in SHRs (Kojima, Kubota, Sato, Yamada, & Harada, 1976). 
Several studies report elevated thyroid secretion rates, though the same studies yield 
equivocal results on iodine uptake and the rate of thyroidal radioactivity release (Fregly, 
1975; Yamabe, 1970). 
Adult offspring of gestationally hypothyroid normotensive rats are reported to 
have elevated systolic, diastolic, and mean arterial pressure when compared with 
euthyroid counterparts (Santos et al., 2012). Given the finding that SHRs are 
hypothyroxinemic in comparison to normotensive strains, hypertension in the SHR may 
be partially attributable to gestational hypothyroidism. 
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Most interestingly, radioactive thyroid ablation and thyroparathyroidectomy of 4 
week old rats have been found to prevent the onset of hypertension in SHRs. Moreover, 
thyroid hormone replacement in these animals was found to trigger a complete restoration 
of hypertension in both studies. (Aoki, 1963b; Rioux & Berkowitz, 1977). However, 
Rioux and Berkowitz found that thyroidectomy at 10 weeks of age did not significantly 
reduce already present hypertension, though it prevented further development of 
hypertension. Notably, despite the maintenance of established hypertension in rats 
thyroidectomized at 10 weeks, heart rate was severely reduced. This suggests that thyroid 
hormone is required for the development of elevated blood pressure, but removal of 
thyroid hormone does not function to reverse an established elevation in blood pressure. 
It is unclear whether thyroid hormone is generally responsible for an increased baseline 
in blood pressure in all rats, or whether a specific abnormality in thyroid hormone-
mediated mechanisms in the SHR is responsible for the development of hypertension, as 
the effect of thyroidectomy on blood pressure has not been compared between SHRs and 
a normotensive strain. 
 
Materials and Methods 
 
Rat Strains 
Spontaneously Hypertensive Rats (SHR) and Wistar Kyoto (WKY) Rats from MNSU’s 
in house breeding program were used. They are descendants of rats supplied by both 
Charles River Laboratories and Taconic.  
Treatment 
21 
 
At four weeks of age, male rats were weaned and divided into two test groups, euthyroid 
(control group) and hypothyroid treatment. Control rats were administered tap water from 
MNSU’s animal care facility. Hypothyroid rats were administered 0.05% methimazole 
and 1.0% perchlorate in drinking water from MNSU’s animal care facility. All rats were 
fed the standard LabDiet 5001 Rodent Diet. At postnatal week 14, a subset of 
hypothyroid rats were removed from treatment and monitored to week 17 (WKY 
Hypothyroid, SHR Hypothyroid (n=4 for each group)). A subset of control rats continued 
to participate in the study through week 17 (WKY Control, SHR Control (n=4)). This 
subset of rats will be referred to as the “recovery subset”. 
Water and Mass Measurement 
 To determine that there was not a strain bias in water consumption between treatment 
groups, water consumption was measured every two days for the first two weeks of 
treatment. Mass was measured using a scale (US-BenchTop-PRO 200g + 0.1g balance). 
Water consumption was measured by cage with each cage housing two rats. Individual 
rats were weighted every two days and water consumption for each two day period was 
divided by the total weight of the two rats.  (WKY Control (cages=5), WKY Hypothyroid 
(cages=5), SHR Control (cages=4), SHR Hypothyroid (cages=4)).  
Weekly mass was measured using a US-BenchTop-PRO 200g + 0.1g balance 
(WKY Control (n=17), WKY Hypothyroid (n=17), SHR Control (n=14), SHR 
Hypothyroid (n=15)) from week 4 to week 14. Mass was also measured at week 17, the 
end of the recovery period, in the recovery subset of animals. 
Serum Collection and Measurement 
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 To confirm thyroid insufficiency in treatment rats, blood was collected at postnatal week 
15 (WKY Control, WKY Hypothyroid, SHR Control, SHR Hypothyroid (n=6/group)). 
To confirm thyroid hormone recovery, blood was collected at postnatal week 17 in the 
recovery subset (WKY Control, WKY Hypothyroid, SHR Control, SHR Hypothyroid 
(n=4/group)). The rats were first anesthetized in an anesthetic chamber using isoflurane 
(3% in oxygen) followed by right ventricular puncture using a 22g needle and 10 mL 
syringe to collect blood. Blood was placed into a serum separator test tube, allowed to 
coagulate for 20 minutes, and then centrifuged at 1100-2000 RCF for 10 minutes. Serum 
was placed into microcentrifuge tubes and frozen at -18 degrees Celcius until assay. 
 Serum T4 was measured using Diagnostic Automation competitive enzyme-linked 
immunosorbant assay (ELISA) test kits. 25 μL of 0, 0.05, 1, 2, 5, 10, 15, and 25 μg/dL 
standards and serum samples were pipetted into coated wells. 100 μL of working 
conjugate reagent was pipetted into each well and mixed thoroughly for 30 seconds, then 
incubated at room temperature for 60 minutes. Following incubation, well contents were 
removed and rinsed 5 times with distilled water. 100 μL of TMB reagent was pipetted 
into each well and contents were gently mixed for 5 seconds, then incubated in the dark 
for 20 minutes.  100 μL of stop solution was pipetted into each well and wells were 
gently mixed for 30 seconds. Absorbance was read at 450 nm with a Thermo Scientific 
Multiskan Spectrum Microplate Photometer. Standard values were used to generate a 
standard curve and concentration values were interpolated for serum samples using the 
standard curve. 
Occlusion Tail-Cuff Photoplethysmography 
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 Starting at postnatal week 4, systolic arterial pressure (SAP) was recorded weekly in a 
subgroup or rats via tail-cuff photoplethysmography (WKY Control (n=10), WKY 
Hypothyroid (n=9), SHR Control (n=8), SHR Hypothyroid (n=10)). Rats were carefully 
placed in clear plastic restraining chambers to limit movement during data collection. 
Rats were placed under a heat lamp to facilitate clear pulse detection, and IITC Life 
Science tail-cuff photoplethysmography sensors were placed on the rats’ tails. BioPac 
software was used to interface between the IITC plethysmography units and a computer, 
which recorded pulse and pressure. Once a pulse was detected, the tail cuff was inflated 
to 300 mmHg, or until a pulse wave was no longer detected. The tail cuff was then slowly 
deflated until the pulse was again detected.  The blood pressure at the reappearance of the 
pulse wave is equal to systolic arterial pressure. This process was repeated for a total of 
six pressure readings. Rats were then returned to their housing. The last three clear 
systolic pressures were averaged for each rat to determine the weekly SAP value. This 
procedure was continued to postnatal week 15. 
Remote Monitoring of Blood Pressure 
  At postnatal week 10, a subgroup of rats was implanted with remote monitoring blood 
pressure transmitters to more accurately measure unstressed blood pressure. Rats greater 
than 150 grams at the time of implant were implanted with Data Sciences International 
TA11PA-C40 PhysioTel transmitters (WKY Control (n=8), WKY Hypothyroid (n=6), 
SHR Control (n=6). Due to growth retardation associated with hypothyroid treatment, 
some rats were less than 150 grams at the time of implant, and therefore were implanted 
with much smaller Data Sciences International TA11PA-C10 PhysioTel transmitters 
(WKY Hypothyroid (n=1), SHR Hypothyroid (n=7)).  
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 For implantation, rats were placed in an anesthetic chamber and anesthetized with 
isoflurane (3% in oxygen). Rats were then removed from the chamber, a mask was placed 
over the nose and mouth, and isoflurane anesthesia was maintained at an appropriate 
depth.  Sterile techniques were followed for all surgical procedures.  The inner surface of 
the thigh was shaved and scrubbed with chlorhexidine, a disinfectant scrub. The rat was 
placed on a heating pad, temperature was recorded rectally, and rectal temperature was 
maintained at 37 degrees Celsius by adjusting the heating pad control. An inguinal 
incision was made, the femoral artery was gently isolated, and the catheter from the 
remote monitoring device was inserted into a branch of the femoral artery and advanced 
into the descending aorta.  The C40 transmitter was placed subcutaneously on the rat’s 
side. The C10 transmitter was placed subcutaneously on the ventral surface of the 
abdomen. The catheter was tied in place with 4-0 silk, and the skin closed with 4-0 nylon.  
The rat received an injection of Rimadyl (caprofen) (10 mg/kg) to control post-op pain. 
The rat was allowed to recover for at least 5 days before data collection began. 
Data was collected from postnatal week 11 to postnatal week 14 (WKY Control 
(n=8), WKY Hypothyroid (n=7), SHR Control (n=6), SHR Hypothyroid (n=7)). The 
transmitters sent a radio signal to a receiver attached to a computer.  Blood pressure was 
monitored in 10 second segments, once an hour, for 48 successive hours out of each 
week.  Batteries were be shut off during the days the rats were not monitored to conserve 
battery life.  Batteries were turned off or on by waiving a magnet over the surface of the 
rat. 
Stress Test 
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As a measure of sympathetic response, the recovery subset of rats (WKY Control, WKY 
Hypothyroid, SHR Control, SHR Hypothyroid (n=4 for each group)) was subjected to a 
stress test at weeks 14 and 17. Heart rate and pressure were sampled continuously via 
remote transmitter for 50 seconds in undisturbed rats for a baseline recording. The rat 
was then placed in a restrainer and the proximal tail was held while heart rate and blood 
pressure were sampled continuously for 50 seconds. The rat was then returned to its 
housing. Stress response was determined as a measure of change from baseline average to 
stressed average in heart rate and pressure. 
Na+ Excretion  
Pressure natriuresis was measured acutely in a subgroup of rats (WKY Control 
(n=6), WKY Hypothyroid (n=6), SHR Control (n=6), SHR Hypothyroid (n=5)). The rat 
was anesthetized using isoflurane anesthetic gas (3% in oxygen) and administered Inactin 
(thiobutabarbital) (100 mg/kg) intraperitoneally once anesthetized. The ventral abdomen 
and neck were shaved. The rat was placed on a heating pad, temperature was recorded 
rectally, and rectal temperature was maintained at 37 degrees Celsius by adjusting the 
heating pad control. An incision was made on the ventral neck and a breathing tube (PE 
240) was inserted into the trachea, a cannula (PE 50) was inserted into the jugular vein 
for saline infusion (12 mL/kg/hr) to maintain fluid balance, and a cannula (PE 50) was 
inserted into the carotid artery and connected to a blood pressure transducer which was 
connected to BIOPAC hardware which interfaced with a computer for recording blood 
pressure and heart rate. The abdomen was opened, and ligation sutures were pre-placed 
around the mesenteric and celiac arteries, and the lower aorta, caudal to the renal (kidney) 
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arteries.  For urine collection, a tube (PE 240) was placed into the bladder lumen and 
stabilized with a purse string suture.    
After a 30-minute period of equilibration, blood pressure was recorded 
continuously on the computer.  Urine was gently aspirated from the bladder tube and 
bladder at the end of each period, measured, and stored at 3 degrees Celsius until 
analysis.  A baseline fifteen-minute urine sample was collected from all rats in both 
groups. Following the baseline period, the artery ligation sutures were tied off, which 
caused a rise in blood pressure.  Urine and blood pressure readings were collected for 
three additional fifteen-minute periods. Urine samples were measured and diluted to 0.3 
mL. 1:100 dilutions of samples were prepared with a Jenway Series 7 Diluter. Sodium in 
urine samples was measured using a Jenway PFP7 Flame Photometer, and pressure 
natriuresis was compared within each strain between control and hypothyroid groups.  
Data Analyses 
Repeated measures two-way ANOVAs followed by a Bonferroni post hoc tests were used 
to determine if there was a significant effect of treatment (hypothyroid or control) or 
strain (SHR or WKY) on mean arterial pressure, diastolic pressure, systolic pressure, 
pulse pressure and heart rate. Two separate repeated measures two-way ANOVAs were 
used for data for weeks 11-14 of treatment and the recovery subset through week 17.  
Weekly blood pressure measurements were normalized by calculating the 
difference between the actual pressure, and the group mean.  A repeated measures two-
way ANOVA, followed by a Bonferroni post hoc test was used to determine if there was 
a significantly difference between strains in hypothyroid effects on mean arterial 
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pressure, diastolic pressure, systolic pressure, pulse pressure and heart rate. Weeks 11-14 
of treatment, and the recovery subset through week 17 were analyzed separately. 
 A one-way ANOVA followed by a Bonferroni post hoc test was used to 
determine if there was a significant effect of strain or treatment on serum T4 at weeks 14 
and 17. 
A two-way ANOVA followed by a Bonferroni post hoc test was also used to 
determine if there was a significant effect of strain or treatment on urine volume 
excretion or Na+ excretion when blood pressure was raised. 
Tertiles of activity were determined for each strain/treatment group. Mean 
diastolic arterial, systolic arterial, mean arterial, and pulse pressures and heart rate were 
determined for high, low, and medium tertiles. For each animal, low means were 
subtracted from high means to determine and compare differences in pressure and heart 
rate base on activity. Repeated measures two-way ANOVAs followed by a Bonferroni 
post hoc tests were used to determine if there was a significant effect of treatment 
(hypothyroid or control) or strain (SHR or WKY) on differences between high and low 
activity values for mean arterial pressure, diastolic pressure, systolic pressure, pulse 
pressure and heart rate. Data for weeks 11-14 of treatment and the recovery subset 
through week 17 were analyzed separately. 
Results 
Serum T4  
Figure 1 summarizes mean serum T4 for animals sacrificed at postnatal week 14 
and postnatal week 17. Serum T4 was significantly lower in WKY hypothyroid rats and 
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SHR hypothyroid rats compared to their respective controls at week 14 as well as 
significantly lower T4 in SHR controls than in WKY controls at week 14. No significant 
differences were detected between any groups in the recovery subset sacrificed at week 
17. 
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Figure 1. The effect of strain and treatment on serum T4 as measured by ELISA. Bars represent mean 
serum T4 ± standard error at postnatal weeks 14 and 17. *p<0.05 between SHR controls and WKY 
controls ***p<0.001 when hypothyroid rats are compared to control rats of the same strain. (n=week 
14;week 17) 
 
Weights 
Figure 2 summarizes mean weekly weights at postnatal week 4 through 14. WKY 
hypothyroid rats and SHR hypothyroid rats had significantly lower weights compared 
to their respective controls from week 6 through week 14. 
Figure 3 summarizes mean weight gain between week 14 and 17 in the recovery 
subset. SHR control rats experienced a significantly lower weight gain compared to 
WKY hypothyroid rats. No significant differences were detected between any other 
groups. 
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Figure 2. The effect of strain and treatment on weight. Bars represent mean weight ± standard error at 
postnatal weeks 4-14. ***p<0.001 when hypothyroid rats are compared to control rats of the same 
strain.  
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Figure 3. The effect of strain and treatment on weight gain between weeks 14 and 17 in the recovery 
subset. Bars represent mean weight gain ± standard error. *p<0.05 between SHR control and WKY 
hypothyroid rats. 
 
Systolic Arterial Pressure by Tail-Cuff Photoplethysmography 
 Figure 4 summarizes mean weekly systolic arterial pressures at postnatal week 4 
through 15 as measured by tail-cuff photoplethysmography. SHR hypothyroid rats had 
significantly lower systolic arterial pressures compared to SHR controls weeks 6-15. 
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WKY hypothyroid rats had significantly lower systolic arterial pressures compared to 
WKY controls at weeks 5, 7, 11-13. WKY treatment groups exhibited a significantly 
lower difference in systolic arterial pressure than that between SHR treatment groups at 
weeks 4, 8, 9, 11, and 13-15. 
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Figure 4. The effect of strain and treatment on systolic arterial pressure as measured by tail-cuff 
photoplethysmography. Bars represent mean systolic arterial pressure ± standard error at postnatal weeks 4-
15. *p<0.05, **p<0.01, ***p<0.001 when hypothyroid rats are compared to control rats of the same strain. 
+p<0.05, ++p<0.01, +++p<0.001 when the magnitude of difference between control and hypothyroid rats is 
compared between SHR and WKY strains. 
Pressure and Heart Rate by Remote Transmitter  
Figure 5 summarizes mean weekly mean arterial pressures at postnatal week 11 
through 17 as measured by remote transmitter. Both the SHR and WKY hypothyroid rats 
had significantly lower mean arterial pressures compared to their respective controls 
weeks 11-14. SHR hypothyroid rats in the recovery subset had significantly lower mean 
arterial pressures compared to SHR controls weeks 15-17. WKY hypothyroid rats in the 
recovery subset had significantly lower mean arterial pressures compared to WKY 
controls at weeks 15-17.  In the hypothyroid SHR, MAP decreased significantly during 
recovery, when compared to week 14.  No significant differences were found between 
strains in mean arterial pressure changes in response during treatment or recovery. 
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Figure 6 summarizes mean weekly systolic arterial pressures at postnatal week 11 
through 17 as measured by remote transmitter. Both the SHR and WKY hypothyroid rats 
had significantly lower systolic arterial pressures compared to their respective controls 
weeks 11-14. Both the WKY and SHR hypothyroid rats in the recovery subset had 
significantly lower systolic arterial pressures compared to their respective controls weeks 
15-17. No significant differences were found between strains in systolic arterial pressure 
response during treatment or recovery. 
Figure 7 summarizes mean weekly diastolic arterial pressures at postnatal week 
11 through 17 as measured by remote transmitter. Diastolic pressure was not significantly 
different in SHR hypothyroid rats compared to SHR controls weeks 11-14, but WKY 
hypothyroid rats had significantly lower diastolic arterial pressures compared to WKY 
controls at weeks 11-14. SHR hypothyroid rats in the recovery subset had significantly 
lower diastolic arterial pressures compared to SHR controls weeks 16-17, but diastolic 
pressure, although remaining low, was not significantly different in WKY hypothyroid 
rats in the recovery subset compared to WKY controls at weeks 15-17.  When compared 
to SHR, WKY rats exhibited a significantly greater change in diastolic arterial pressure in 
response to treatment weeks 11-14.  In hypothyroid SHR, diastolic pressure decreased 
significantly during recovery, when compared to week 14.   No significant differences 
were found between strains in the change in diastolic arterial pressure in response to 
treatment withdrawal weeks 15-17. 
Figure 8 summarizes mean weekly pulse pressures at postnatal week 11 through 
17 as measured by remote transmitter.  Both the WKY and SHR hypothyroid rats had 
significantly lower pulse pressures compared to their respective controls weeks 11-14. 
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SHR hypothyroid rats in the recovery subset had significantly lower pulse pressures 
compared to SHR controls at week 15. WKY hypothyroid rats in the recovery subset had 
significantly lower pulse pressures compared to WKY controls at week 17.  SHRs 
exhibited a significantly greater response of pulse pressure to treatment compared to 
WKY rats weeks 11-14. The recovery subset of SHRs exhibited a significantly greater 
change in pulse pressure in response to treatment compared to the recovery subset of 
WKY rats at week 15.  In the hypothyroid SHR, pulse pressure increased significantly 
during recovery when compared to week 15. 
Figure 9 summarizes mean weekly heart rate at postnatal week 11 through 17 as 
measured by remote transmitter. Both the WKY and SHR hypothyroid rats had 
significantly lower heart rates compared to their respective controls weeks 11-14. WKY 
rats exhibited a significantly greater change in heart rate in response to treatment 
compared to SHRs weeks 12-14. No significant differences were found between strains 
in response of heart rate to treatment withdrawal weeks 15-17. 
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Figure 5. The effect of strain and treatment on mean arterial pressure as measured by remote transmitter. 
Bars represent mean, mean arterial pressure ± standard error at postnatal weeks 11-17. *p<0.05, **p<0.01, 
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***p<0.001 when hypothyroid rats are compared to control rats of the same strain. (n=week 11-14;week 
15-17) 
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Figure 6. The effect of strain and treatment on systolic arterial pressure as measured by remote transmitter. 
Bars represent mean systolic arterial pressure ± standard error at postnatal weeks 11-17. *p<0.05, 
**p<0.01, ***p<0.001 when hypothyroid rats are compared to control rats of the same strain. (n=week 11-
14;week 15-17) 
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Figure 7. The effect of strain and treatment on diastolic arterial pressure as measured by remote transmitter. 
Bars represent mean diastolic arterial pressure ± standard error at postnatal weeks 11-17. *p<0.05, 
**p<0.01, ***p<0.001 when hypothyroid rats are compared to control rats of the same strain. +p<0.05, 
++p<0.01, +++p<0.001 when the magnitude of difference between control and hypothyroid rats is 
compared between SHR and WKY strains. (n=week 11-14;week 15-17) 
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Figure 8. The effect of strain and treatment on pulse pressure as measured by remote transmitter. Bars 
represent pulse pressure ± standard error at postnatal weeks 11-17. *p<0.05, **p<0.01, ***p<0.001 when 
hypothyroid rats are compared to control rats of the same strain. +p<0.05, ++p<0.01, +++p<0.001 when the 
magnitude of difference between control and hypothyroid rats is compared between SHR and WKY strains. 
(n=week 11-14;week 15-17) 
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Figure 9. The effect of strain and treatment on heart rate as measured by remote transmitter. Bars represent 
mean heart rate ± standard error at postnatal weeks 11-17. *p<0.05, **p<0.01, ***p<0.001 when 
hypothyroid rats are compared to control rats of the same strain. +p<0.05, ++p<0.01, +++p<0.001 when the 
magnitude of difference between control and hypothyroid rats is compared between SHR and WKY strains. 
(n=week 11-14;week 15-17) 
Activity Differences 
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 Figure 10 summaries mean difference between heart rate at high and low tertiles 
of activity as measured by remote transmitter. Hypothyroid SHRs and hypothyroid 
WKYs had a significantly blunted response of heart rate to increased activity compared 
to their respective controls weeks 11-14. No significant differences in heart rate response 
to increased activity were found between any groups at weeks 15-17. 
 No significant differences were detected between any groups in mean difference 
between high and low activity for parameters other than heart rate. 
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Figure 10. The effect of strain and treatment on difference between heart rate at high activity and low 
activity at weeks 11-17 as measured by remote transmitter. Bars represent mean difference between high 
activity and low activity ± standard error at postnatal weeks 11- 17. **p<0.01, ***p<0.001 when 
hypothyroid rats are compared to control rats of the same strain. 
 
Stress Test 
 Figure 11A summarizes mean differences between resting and stressed systolic 
arterial pressure as measured by remote transmitter. SHR controls had a significantly 
greater increase in systolic arterial pressure with stress than WKY controls at weeks 14 
and 17, and a significantly greater increase in systolic arterial pressure with stress than 
SHR hypothyroid rats at week 14. During recovery at week 17, SHR hypothyroid rats had 
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a significantly greater increase in systolic arterial pressure with stress than WKY 
hypothyroid rats. 
 Figure 11B summarizes mean difference between resting and stressed pulse 
pressure as measured by remote transmitter. SHR controls had a significantly greater 
increase in pulse pressure with stress than WKY controls at weeks 14 and 17, and a 
significantly greater increase in pulse pressure with stress than SHR hypothyroid rats at 
week 14.  
 No differences were found between any groups in the effects of stress on heart 
rate, mean arterial pressure, or diastolic pressure. 
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Figure 11. The effect of strain and treatment on difference between resting and stressed systolic arterial 
pressure (A) and pulse pressure (B) as measured by remote transmitter. Bars represent mean systolic 
arterial pressure (A) and pulse pressure (B) ± standard error at postnatal weeks 14 and 17. *p<0.05 
Pressure Natriuresis 
 Figure 12 summarizes mean Na+ excretion at four 15 minute periods at postnatal 
week 15 as measured by flame photometer. WKY hypothyroid rats had significantly 
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higher pressure natriuresis compared to WKY controls periods 2-4, and sodium excretion 
was greater than baseline values during period 4.  
 No significant differences were found between any groups in urine volume 
excretion. 
 Figure 13 summarizes mean arterial pressure at eight 7.5 minute intervals at 
postnatal week 15 as measured by BIOPAC hardware. No significant differences in mean 
arterial pressure were found between WKY hypothyroid and SHR hypothyroid rats and 
their respective controls. 
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Figure 12. The effect of strain and treatment on Na+ excretion as measured by flame photometer. Bars 
represent mean Na+ excretion ± standard error at each 15 minute period at postnatal week 14. *p<0.05, 
**p<0.01, ***p<0.001 when WKY hypothyroid rats are compared to WKY control rats. Arrow represents 
ligation of celiac and mesenteric arteries and abdominal aorta caudal to the kidneys. 
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Figure 13. The effect of strain and treatment on pressure response as measured by BIOPAC hardware. Bars 
represent mean, mean arterial pressure ± standard error at 7.5 minute intervals at postnatal week 14.  Arrow 
represents ligation of celiac and mesenteric arteries and abdominal aorta caudal to the kidneys. 
 
Discussion 
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 Induction of hypothyroidism in experimental animals with methimazole and 
perchlorate treatment was confirmed by measuring a reduction in total serum T4.  
Furthermore, treated animals exhibited severe growth retardation, an effect consistent 
with overt developmental hypothyroidism. When treatment was withdrawn, serum T4 was 
normalized and weight was gained at a rate that was similar to their respective controls, 
suggesting of a return to euthyroid status. 
 Consistent with previous results (Aoki, 1963b; Rioux & Berkowitz, 1977), tail-
cuff photoplethysmography indicated that hypothyroidism induced at weaning prevented 
the development of hypertension in SHR.  However, in WKY rats, the effect of 
hypothyroidism on systolic blood pressure was minimal.  Conversely, remote transmitter 
data showed a comparable reduction of systolic arterial pressure and mean arterial 
pressure in hypothyroid SHRs and hypothyroid WKY rats when compared to their 
respective controls. The stress test data provide a potential explanation for the 
discrepancy between tail-cuff photoplethysmography and remote transmitter data. SHR 
control rats exhibited a much greater increase in systolic arterial pressure under stressed 
conditions than WKY rats, but this exaggerated response was absent in the hypothyroid 
SHRs. Thus, during tail cuff photoplethysmography, the stressed systolic arterial pressure 
in the control SHRs was much higher than that of the hypothyroid SHRs, which did not 
exhibit an exaggerated stress response, resulting in an exaggerated difference in the 
systolic arterial pressures between SHR controls and SHR hypothyroid animals.  
Potential explanations of the reduction of pressure in response to stress observed 
in hypothyroid SHRs are decreased sensitivity to adrenergic stimulation, lower blood 
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volume, and reduced maximum cardiac output of the heart due to morphological changes 
associated with hypothyroidism. Prior research indicates that the effects of thyroid 
hormone on the heart, in stress-free environment, are independent of the beta adrenergic 
receptors (Bachman et al.). Additionally, the present study found that pressure changes 
associated with changes in activity were normal, indicative of a normal response despite a 
reduction in baseline pressures. These observations support the idea that the reduction in 
stress-induced response of systolic blood pressure is due to morphological changes 
resulting in a reduction in cardiac output.  However, it cannot be ruled-out that alterations 
in adrenergic signaling occur in the hypothyroid state; resulting in a lower the maximum 
sympathetic response to a stressful environment. 
 During treatment, diastolic arterial pressure was reduced in hypothyroid WKY 
animals compared to WKY controls, but hypothyroid SHRs did not display significantly 
lower diastolic arterial pressure compared to control SHRs. However, when treatment 
was withdrawn, the diastolic arterial pressures of the SHR hypothyroid rats dropped and 
were significantly lower than those of the SHR controls. WKY hypothyroid rats were not 
observed to have significantly reduced diastolic arterial pressure compared to their 
controls during the recovery period, but this is may be a limitation of n, as the mean and 
systolic arterial pressures remained reduced compared to controls during this time period.  
If the reductions in mean arterial and systolic arterial pressure in the hypothyroid 
SHRs were due to a reduction in resistance or blood volume, we would anticipate a 
corresponding reduction in diastolic pressure. However, the SHR hypothyroid rats did not 
experience a reduction in diastolic pressure indicating that the reductions in mean arterial 
and systolic arterial pressure are most likely due to the reduction in stroke volume (Danzi 
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& Klein, 2003; Polikar, Burger, Scherrer, & Nicod, 1993) and reductions in contractility 
and ejection speed observed in hypothyroidism.   
A potential explanation of the difference in effect of hypothyroid treatment on 
diastolic arterial pressure between strains could be endothelial dysfunction (Kung & 
Luscher) observed in SHRs. Evidence suggests that SHRs have altered endothelial 
function (Mirsky, Pfeffer, Pfeffer, & Braunwald). Interestingly, thyroid hormone 
signaling is involved in the synthesis of nitric oxide (Virdis et al.). Considering this, an 
impaired ability of the endothelium to release vasodilatory paracrine agents may indicate 
that the SHR is especially dependent on thyroid mediated nitric oxide synthesis.  
Sustained reductions in systolic, diastolic, and mean arterial pressures in 
hypothyroid animals persisted, even after three weeks of treatment withdrawal, which is 
contrary to previous studies (Rioux & Berkowitz) and is indicative of lasting 
morphological changes induced by hypothyroidism at weaning. Studies of gestational 
hypothyroidism have reported permanent increases in blood pressure despite return to 
euthyroid status and have outlined changes in the autonomic nervous system’s control of 
blood pressure as a cause (Mittag, Davis, Vujovic, Arner, & Vennstrom; Santos et al.). It 
is possible that treatment at weaning also induced changes in autonomic nervous system 
control of blood pressure. A decrease in blood pressure rather than increase may be due 
to a difference in timing of hypothyroidism. 
 The reductions in pulse pressure and heart rate in hypothyroid SHRs and 
hypothyroid WKY animals compared to their respective controls are consistent with 
clinical observations of reduced heart rate and pulse pressure in hypothyroid human 
patients. However, the reduction in pulse pressure observed clinically is typically due to 
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diastolic hypertension, not systolic hypotension, which was observed in hypothyroid 
SHRs the present study. As prior clinical studies observed adult onset hypothyroidism 
and subclinical hypothyroidism, the difference in timing of the onset of hypothyroidism 
in the present study is a potential explanation for these differences. The observed 
differences in effect of hypothyroid treatment on pulse pressure between strains could be 
due to increased arterial stiffness (Safar, Chamiot-Clerc, Dagher, & Renaud) and left 
ventricular dysfunction (Mirsky et al.) observed in SHRs. Increased arterial stiffness in 
SHRs compared to WKYs provides an explanation for the high pulse pressure observed 
in control SHRs. Left ventricular dysfunction has been observed in hypothyroidism 
(Biondi et al.) and may be due to alterations in myosin chain expression that have been 
observed in hypothyroidism (I. Klein & Danzi). Considering that diastolic function is 
impaired in euthyroid SHR, SHRs may be more vulnerable to alterations in myosin chain 
expression.  
While hypothyroid SHRs exhibited a smaller reduction in heart rate compared to 
WKYs, the heart rates of the two hypothyroid groups did not significantly differ. This 
difference in reduction in heart rate is most likely due to the lower baseline heart rate of 
the SHR compared to that of the WKY(van den Buuse). 
 A strain specific increase in pressure natriuresis was observed in WKY 
hypothyroid rats compared to WKY controls, but in hypothyroid SHRs, a non-significant 
increase in pressure natriuresis was measured.  If these acute observations are 
representative of chronic kidney behavior, WKY hypothyroid animals may experience a 
reduction in blood volume compared to controls. This is consistent with the reduced 
blood volume observed in hypothyroidism in humans (Danzi & Klein, 2003) and may 
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provide another potential explanation for the strain specific reduction in diastolic arterial 
pressure under treatment in WKY rats.  
Additionally, pressure natriuresis is related to endothelial function and endothelial 
function is impaired in the SHR (Mirsky et al.). Nitric oxide has known involvement in 
pressure natriuresis (Guarasci & Kline) and thyroid hormone signaling is involved in its 
synthesis (Virdis et al.). Since nitric oxide synthase inhibition is associated with 
decreased pressure natriuresis and nitric oxide synthase is positively regulated by thyroid 
hormone, augmented pressure natriuresis in hyperthyroidism and blunted pressure 
natriuresis in hypothyroidism would be anticipated. However, hyperthyroidism blunts the 
pressure natriuresis response in rats, but chronic hypothyroidism is not associated with an 
alteration of the pressure natriuresis response (Vargas et al., 1994) and the present study 
found augmented pressure natriuresis in hypothyroid WKYs compared to the controls . 
This suggests that alternative mechanisms regulating pressure natriuresis compensate for 
chronic reduction of nitric oxide synthase activity associated with hypothyroidism. 
Thyroid hormone’s effect on the synthesis of nitric oxide may be of greater importance in 
the SHR, due to the underlying endothelial dysfunction, and they may lack the natriuretic 
compensatory mechanism that appears to be present in the WKY. This may be a potential 
explanation as to why hypothyroid SHRs did not experience a significant elevation in 
pressure natriuresis when compared to their controls. This finding also emphasizes that 
hypothyroidism likely induces a multifaceted effect on the cardiovascular system. 
Although there is clear evidence that thyroid hormone has direct effects on the 
heart, vasculature and autonomic nervous control of blood pressure, hypothyroidism is a 
systemic condition and it cannot be ruled out that the observed effects are the result of an 
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indirect effect. For example, induction of hypothyroidism through thyroid inhibition 
increases TSH and TRH by removing negative feedback inhibition as well as disrupting 
other hormone pathways (Brent, 2012; Burstein, Draznin, Johnson, & Schalch; Miell et 
al., 1993). It is therefore possible that some effects observed in the present study are due 
to effects related to treatment and are not directly associated with thyroid hormone action. 
However, given that prior literature identifies direct and indirect action of thyroid 
hormone on the cardiovascular system, it is a reasonable assumption that the observations 
of the present study are due to direct and indirect effects of reduced thyroid hormone. 
Weight gain is associated with an increase in blood pressure (Masuo, Mikami, 
Ogihara, & Tuck) and it is possible that effects seen in the present study were related to 
growth retardation induced by hypothyroidism. However, the recovery subset of rats in 
the present study did not experience a significant increase in systolic or mean arterial 
pressure, despite returning to euthyroid status and gaining weight. This observation 
suggests that growth retardation was not the cause of the reductions in systolic and mean 
arterial pressure experienced by hypothyroid animals.  
In revisiting our hypotheses, we reach several conclusions. First, inhibition of 
thyroid gland activity resulted in a decrease in mean arterial pressure in SHRs when 
compared to controls that was equal to the decrease found in WKY rats given the same 
treatment. This finding indicates abnormal thyroid hormone action following weaning is 
not a major factor in the development of hypertension in the SHR. However, differences 
in response to treatment in diastolic arterial pressure and pulse pressure between the SHR 
and WKY rats are indicative of strain differences of thyroid hormone action in 
cardiovascular system. 
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Second, inhibition of thyroid gland activity in SHRs resulted in a smaller increase 
in systolic arterial pressure in response to acute stress when compared to euthyroid SHRs, 
but no significant differences in stress response were observed between hypothyroid and 
control WKYs. This indicates that hypothyroid treatment reduced the effect of 
sympathetic stimulation on systolic arterial pressure in SHRs, but not in WKY rats. 
Lastly, hypothyroid treatment resulted in significantly greater pressure natriuresis 
in WKY rats when compared to WKY euthyroid controls. However, no significant 
differences in increases in pressure natriuresis were found between control SHRs and 
hypothyroid SHRs. This indicates that sustained hypothyroidism beginning at weaning 
increases the pressure natriuresis response in WKY rats, but not SHR.    
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